Cargando…
Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells
Advanced bladder cancer (BC) (local invasive and/or metastatic) is not curable even with cytotoxic chemotherapy, immune checkpoint inhibitors, and targeted treatment. Targeting GSK-3β is a promising novel approach in advanced BC. The induction of autophagy is a mechanism of secondary resistance to v...
Autores principales: | Shirono, Yuko, Bilim, Vladimir, Anraku, Tsutomu, Kuroki, Hiroo, Kazama, Akira, Murata, Masaki, Hiruma, Kaede, Tomita, Yoshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297715/ https://www.ncbi.nlm.nih.gov/pubmed/37366889 http://dx.doi.org/10.3390/curroncol30060406 |
Ejemplares similares
-
Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2022) -
Advanced Bladder Cancer: Changing the Treatment Landscape
por: Bilim, Vladimir, et al.
Publicado: (2022) -
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma
por: Murata, Masaki, et al.
Publicado: (2023) -
Histone deacetylase 6 inhibition in urothelial cancer as a potential new strategy for cancer treatment
por: Kuroki, Hiroo, et al.
Publicado: (2021) -
Development of patient-derived tumor organoids and a drug testing model for renal cell carcinoma
por: Kazama, Akira, et al.
Publicado: (2021)